Clinical trial
Post-marketing Study to Collect Safety Data in Heart Transplant Patients…
NCT00134940 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00134940 |
|---|---|
| Title | Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus |
| Official title | A Non-interventional Protocol to Collect Prospective and Retrospective Data in Patients Receiving Everolimus to Prevent Acute Rejection Following Cardiac Transplantation |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Coronary Heart Disease |
| Enrollment | 100 |
| Start date | Jan 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Aug 25, 2005 |
| Last update posted | Jun 16, 2011 |
| Countries | Austria, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: